首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system
【24h】

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system

机译:基于目前的分期系统,肿瘤大小对1A期非小细胞肺癌解剖肺切除术后预后的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Anatomic segmentectomy may achieve results comparable to lobectomy for early-stage non-small cell lung cancer. The 7th edition of the AJCC Cancer Staging Handbook stratified the previous T1 tumor designation into T1a and T1b subsets, which still define stage 1A node-negative non-small cell lung cancer. We are left to hypothesize whether this classification may aid in directing the extent of surgical resection. We retrospectively reviewed our anatomic segmentectomy and lobectomy management of stage 1A non-small cell lung cancer to determine differences in survival and local recurrence rates based on the new stratification. Methods: We performed a retrospective review of 429 patients undergoing resection of pathologically confirmed stage 1A non-small cell lung cancer via lobectomy or anatomic segmentectomy. Primary outcome variables included mortality, recurrence, and survival. Recurrence-free and cancer-specific survivals were estimated using the Kaplan-Meier method. Results: Patients undergoing segmentectomy were older than patients undergoing lobectomy (mean age 69.2 vs 66.8 years, P < .006). The mean preoperative forced expiratory volume in 1 second was significantly lower in the segmentectomy group than in the lobectomy group (71.8% vs 81.1%, P = .02). Mortality was similar after segmentectomy (1.1%) and lobectomy (1.2%). There was no difference in mortality, recurrence rates (14.0% vs 14.7%, P = 1.00), or 5-year cancer-specific survival (T1a: 90% vs 91%, P = .984; T1b: 82% vs 78%, P = .892) when comparing segmentectomy and lobectomy for pathologic stage 1A non-small cell lung cancer, when stratified by T stage. Conclusions: Anatomic segmentectomy may achieve equivalent recurrence and survival compared with lobectomy for patients with stage 1A non-small cell lung cancer. Prospective studies will be necessary to delineate the potential merits of anatomic segmentectomy in this setting.
机译:目的:对于早期非小细胞肺癌,解剖节段切除术可以获得与肺叶切除术相当的结果。 AJCC癌症分期手册的第7版将以前的T1肿瘤名称分为T1a和T1b子集,它们仍然定义了1A期淋巴结阴性的非小细胞肺癌。我们只能假设这种分类是否有助于指导手术切除的范围。我们回顾性地回顾了我们的1A期非小细胞肺癌的解剖节段切除术和肺叶切除术的治疗方法,以确定基于新分层的生存率和局部复发率的差异。方法:我们对429例通过肺叶切除术或解剖节段切除术切除经病理证实的1A期非小细胞肺癌的患者进行了回顾性研究。主要结果变量包括死亡率,复发率和生存率。使用Kaplan-Meier方法估算无复发和癌症特异性生存率。结果:接受节段切除术的患者比接受肺叶切除术的患者年龄大(平均年龄69.2 vs 66.8岁,P <.006)。分段切除术组在1秒内的平均术前强迫呼气量显着低于肺叶切除术组(71.8%vs 81.1%,P = .02)。节段切除术(1.1%)和肺叶切除术(1.2%)后的死亡率相似。死亡率,复发率(14.0%对14.7%,P = 1.00)或5年癌症特异性生存率(T1a:90%对91%,P = .984; T1b:82%对78%)没有差异。 ,P = .892),当按T期分层对病理1A期非小细胞肺癌的节段切除术和肺叶切除术进行比较时。结论:对于1A期非小细胞肺癌患者,解剖节段切除术与肺叶切除术相比可以达到相同的复发率和生存率。在这种情况下,有必要进行前瞻性研究来描述解剖节段切除术的潜在优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号